167 results
Page 3 of 9
8-K
EX-99.1
btlucvnzccl6fdorc1h
19 Mar 20
Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
6:04am
8-K
EX-99.1
f5ze85hjvk
14 Jan 20
Soligenix – Advancing to Important Inflection Points
1:05pm
8-K
EX-99.1
oivg6
17 Sep 19
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
6:59am
8-K
EX-99.1
amej7f00
11 Sep 19
Soligenix Appoints Jonathan Guarino as Chief Financial Officer
4:15pm
8-K
EX-99.1
s3hdpr
29 Aug 19
Final topline results remain on target for first half 2020
4:30pm
8-K
EX-99.1
6974gr7t7yj71c4
9 Jul 19
Soligenix Announces Appointment of Diane L. Parks
12:00am
8-K
EX-99.1
fxhbrq2 e3ij02
23 Apr 19
Soligenix – Advancing to Important Inflection Points
4:16pm
8-K
EX-99.1
ktvttw4aph3dq4 y3c9
15 Oct 18
Other Events
7:00am
8-K
EX-99.1
dovd6c1dy4vexs0
25 Jul 18
Soligenix Announces Appointment of
9:21am
8-K
EX-99.1
u7k52
19 Jul 18
Other Events
6:30am
8-K
EX-99.1
8ruw sh10xg7zm0zk8xu
2 Jul 18
Soligenix, Inc. Prices $8,000,000 Public Offering At The Market
4:15pm
8-K
EX-99.2
iqf9jj0 39w
2 Jul 18
Soligenix, Inc. Prices $8,000,000 Public Offering At The Market
4:15pm
424B4
4xnh2 efnhrwrz
29 Jun 18
Prospectus supplement with pricing info
12:00am